Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.

Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check3 days agoChange DetectedThe study record appears unchanged, with no discernible updates to its content or presentation.SummaryDifference0.1%

- Check10 days agoChange DetectedThe record describes a Phase 1 study of CLR 131 for children, adolescents, and young adults with relapsed or refractory cancers, including its eligibility criteria, treatment plan, and outcome measures. It also provides the study’s recruitment status and participating locations.SummaryDifference64%

- Check17 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check24 days agoChange DetectedA sitewide NIH banner announces a website transition and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check31 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.